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Abstract: Drug loaded implants are a new, versatile technology platform to deliver a localized 
payload of drugs for various disease models. One example is the implantable nanoplatform for 
chemo-radiation therapy where inert brachytherapy spacers are replaced by spacers doped with 
nanoparticles (NPs) loaded with chemotherapeutics and placed directly at the disease site for 
long-term localized drug delivery. However, it is difficult to directly validate and optimize the 
diffusion of these doped NPs in in vivo systems. To better study this drug release and diffusion, 
we developed a custom macroscopic fluorescence imaging system to visualize and quantify 
fluorescent NP diffusion from spacers in vivo. To validate the platform, we studied the release 
of free fluorophores, and 30 nm and 200 nm NPs conjugated with the same fluorophores as a 
model drug, in agar gel phantoms in vitro and in mice in vivo. Our data verified that the diffu-
sion volume was NP size-dependent in all cases. Our near-infrared imaging system provides 
a method by which NP diffusion from implantable nanoplatform for chemo-radiation therapy 
spacers can be systematically optimized (eg, particle size or charge) thereby improving treat-
ment efficacy of the platform.
Keywords: optical imaging, fluorescence, drug delivery, brachytherapy, treatment 
monitoring
Introduction
Implantable drug delivery systems placed at the site of disease represents an appealing 
approach to delivering a number of different classes of drugs that cannot be effectively 
delivered via more common routes such as intravenous, oral, or topical administration. 
An implantable drug reservoir can increase the bioavailability of the drug without the 
need for multiple injections.1 To prevent a secondary intervention for drug reservoir 
removal, many implantable devices have been made biodegradable. The degradation 
rate of the implant combined with the diffusivity of the drug makes understanding and 
predicting the release profile in vivo a challenge. For example, polymer-dexamethasone 
implants are used for intravital dosing for persistent macular edema, showing signifi-
cant dexamethasone levels up to 6 months post-implantation. However, detection of 
drug levels was performed using common techniques, such as liquid chromatography-
tandem mass spectrometry in sacrificed animals, which greatly limits the amount 
of data collected to a single time point.2 Similar post-sacrifice analysis techniques 
or complex biopsies were used in determining diffusion profiles of clinically used 
biodegradable implants in delivering insulin, steroids, chemotherapeutics, antibiot-
ics, or analgesics.1 In this manuscript, we aim to develop an imaging platform that 
can be used to understand the mechanism and quantification of drug diffusion from 
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these implants. We also aim to evaluate the size-dependent 
diffusion properties using real-time diffusion in live animals 
by studying different sized fluorescent silica nanoparticles 
(NPs) incorporated in these implants.
We have fabricated a modified brachytherapy spacer for 
application in localized drug delivery during the brachyther-
apy procedure. During brachytherapy, clinicians use identical 
but inert spacers to achieve spatial and temporal distribution 
of radioactive brachytherapy seeds for highly controlled 
radiation dosing of the tumor. However, these spacers 
themselves do not currently have any therapeutic function.3–5 
Since these spacers are frequently used as internal radiation 
therapy guides in clinics, this offers an opportunity for in 
situ delivery of drugs by fabricating spacers which are doped 
with chemotherapeutic drugs or radiosensitizers, without 
additional discomfort to the patient. Our group leveraged 
this opportunity and fabricated “implantable nanoplatform 
for chemo-radiation therapy” (INCeRT) spacers for localized 
delivery of therapeutics.6
While systemic chemotherapy administered intravenously 
is routinely used, both with and without radiation therapy 
in the management of cancer, poor tumor accumulation 
and systemic toxicity due to intravenous delivery are major 
limitations when creating a personalized treatment plan.7–9 
Localized delivery of a chemotherapy agent would eliminate 
the high systemic toxicities while allowing for an effective 
and concentrated dose directly at the tumor site. The robust 
INCeRT platform can be tailored for a controlled and con-
tinuous release of the drug/radiosensitizer from the spacer for 
sustained local delivery of a high therapeutic dose optimal 
for long-term brachytherapy treatments. The size, shape, and 
delivery procedure for INCeRT spacers are identical to spac-
ers used in current clinical settings, with the added benefit 
of local chemotherapy. This will act as a slow-release drug 
reservoir for simultaneous combinatorial chemo and radiation 
therapy. However, to prove our concept of slow and sustained 
drug release from INCeRT implants, it is imperative to study 
the release of the drug and diffusion properties in real time 
using a non-invasive method. Thus, to demonstrate this, we 
have used near-infrared (NIR) fluorophore, Cyanine 7.5 
(Cy7.5) as a model drug to incorporate in the INCeRT spac-
ers and study the diffusion in real time using optical imaging 
methods. We have further incorporated Cy7.5 in the NPs to 
evaluate the size-dependent release and diffusion from the 
spacers. This release is conceptually illustrated in Figure 1A, 
demonstrating the NP release from the spacer and the subse-
quent release of the therapeutic agent from the NP. The use 
of Cy7.5 conjugated NPs in the spacer allows for studying 
the diffusion properties of materials with different molecular 
weights or sizes when embedded in the implants or spacers.
Fluorescence imaging has a number of advantages for this 
application, including the ability to perform non-invasive serial 
imaging over time on the same animal(s), the broad availabil-
ity of biocompatible cell labeling techniques (red fluorescent 
proteins, Alexa Fluor [AF] dyes, and Cyanine dyes), the lack 
of ionizing radiation, and the relatively low cost of the instru-
mentation involved.10–12 To achieve this, we developed and 
validated a new broad-field fluorescence imaging system to 
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Figure 1 INCeRT platform schematic diagram and high magnification electron microscopy images of spacers.
Notes: (A) Illustration of intradermal spacer diffusion. As the spacer degrades, fluorescent silica nanoparticles are released for a slow sustained diffusion. Further, drug 
encapsulated in the nanoparticle can be released. A transmission electron microscopy image of (B) 30 nm and (C) 200 nm silica nanoparticles. (D) A series of scanning 
electron microscopy images of a flash frozen and fractured spacer with uniform distribution of nanoparticles. As magnification of the cross sectional area is enhanced in each 
image (i–iii), the structure of the silica pockets is observable. The magnified region in the right-most frame allows direct visualization of nanoparticles in the silica pockets.
Abbreviation: INcerT, implantable nanoplatform for chemo-radiation therapy.
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1215
Near-infrared fluorescence imaging platform of nanoparticle spacers
observe NP diffusion in bulk biological tissue. This allowed us 
to systematically quantify diffusion both in phantoms in vitro 
and in mice in vivo. Moreover, we chose to perform imaging 
in the NIR “diagnostic window” wavelength region (corre-
sponding to approximately 650–850 nm), where light absorp-
tion and scatter is minimal compared to the visible range.10 We 
performed in vitro studies with free AF 750 dye and NPs of 
different sizes (30 and 200 nm) in agar gel phantoms in vitro 
and analyzed the diffusion over time. We also performed stud-
ies for 2 weeks in mice tracking and analyzing the diffusion in 
vivo. As will be shown, we were able to quantify size-based 
diffusion in both models. As such, this technology represents 
a new platform by which we can optimize INCeRT NP 
characteristics – for example with respect to size and surface 
chemistry – to achieve sustained chemotherapy release from 
the spacers over weeks or months in vivo.
Methods and materials
Fabrication of NPs and spacers
Synthesis of NIR fluorescent silica NPs
The synthesis of conjugated Cy7.5 silica NPs (conCy7.5-NPs) 
was carried out using a slightly modified oil-in-water micro-
emulsion method previously reported by Kumar et al.13,14 
To conjugate the Cy7.5-N-hydroxysuccinimide (NHS) ester 
fluorophore into the NPs, Cy7.5-silane was prepared by 
conjugating Cy7.5-NHS ester (Lumiprobe Corporation, Hal-
landale, FL, USA) to a silane precursor using (3-aminopropyl) 
triethoxysilane (Sigma-Aldrich Co., St Louis, MO, USA) 
under argon atmosphere. The NPs were prepared at room 
temperature with 2.2% dioctyl sulfosuccinate sodium salt 96% 
(AOT) (Sigma-Aldrich Co.) (wt/v) in 10 mL high performance 
liquid chromatography water, followed by the addition of 
1-butanol and Cy7.5-silane at 1,200 rpm stirring. After 15 min-
utes, vinyltrimethoxysilane (Sigma-Aldrich Co.) was added 
and the mixture was continuously stirred for 45 minutes, at 
which point, ammonium hydroxide (Sigma-Aldrich Co.) was 
added and the reaction was covered and left to stir overnight. 
The NPs’ suspension was then dialyzed against distilled water 
for 48 hours at room temperature, using a cellulose membrane 
(Thermo Fisher Scientific, Waltham, MA, USA) with a cutoff 
size of 12–14 kDa. Following dialysis, the NPs were sterile 
filtered (0.45 µm) and stored at 4°C for future use.
Fabrication of poly(lactic-co-glycolic) acid (PLGA) 
spacers doped with NPs
The fabrication of spacers was carried out by previously 
optimized protocols from our group in two steps that involve: 
a) extraction of NPs from the aqueous media and b) polymer 
extrusion along with NPs.6 Briefly, the dialyzed NPs were 
frozen and left in the dark under vacuum to dry overnight. The 
dried NP pellet was re-dispersed in minimum amount of dim-
ethyl sulfoxide (Sigma-Aldrich Co.) via sonication. Following 
that, 250 mg of PLGA (molecular weight [MW] 54–69 kDa, 
Sigma-Aldrich Co.) was dissolved in minimum amount of 
chloroform. The NP slurry was then added to the polymer 
slurry and the entire mixture was mixed thoroughly and left 
in 4°C for 30 minutes or until the mixture became a viscous 
paste. The paste was then transferred to a 1 mL syringe. All 
air bubbles were carefully removed from the syringe and the 
mixture was then extruded into Tygon silicone tubing (inner 
diameter 0.8 mm, Thermo Fisher Scientific) using an infusion 
pump (Harvard Apparatus, Holliston, MA, USA). After infu-
sion, the ends were clipped with binder clips, cylinders were 
dried overnight then cooled to room temperature and cut into 
5 mm length for storage. For fabricating the free Cy7.5 dye 
doped PLGA spacers, a similar process was used, substituting 
the NP slurry with Cy7.5 in dimethyl sulfoxide solution.
characterization of NPs and spacers
Transmission electron microscopy images of 30 nm and 
200 nm NPs are shown in Figure 1B and 1C, respectively 
(JEM-100CX microscope; JEOL, Tokyo, Japan) were 
obtained using an acceleration voltage of 80 kV. The speci-
mens were prepared by drop casting the sample dispersion 
onto an amorphous carbon coated 300 mesh copper grid. 
Dynamic light scattering (90Plus zeta sizer, Brookhaven Inc., 
Holtsville, NY, USA) was used to measure the hydrodynamic 
diameter of the conCy7.5-NPs. To prepare samples for scan-
ning electron microscopy, spacers were flash frozen in liquid 
nitrogen then fractured with a cooled razor. Fractured and 
non-fractured spacers were attached to a specimen mount 
using a conductive carbon adhesive tab and then coated with 
10–15 nm of carbon using a vacuum evaporator (DV502; 
Denton Vacuum, Moorestown, NJ, USA). Samples were 
imaged in both secondary electrons and back-scattered elec-
trons mode (S-4800 field emission SEM; Hitachi Ltd., Tokyo, 
Japan) at 5 kV and are shown in Figure 1D. Energy-dispersive 
X-ray spectroscopy analysis was carried out by selecting 
several regions of interest from the spacers and evaluating 
the elemental composition of the region of interest.
Fluorescence imaging system
A schematic diagram and photograph of our custom designed 
fluorescence imaging system is shown in Figure 2A and B, 
respectively. Samples (mice or agar phantoms) were placed 
on a platform and trans-illuminated with the output of a 
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tunable Titanium:Sapphire laser (Mai Tai, XF-1; Spectra-
Physics, Inc., Santa Clara, CA, USA). Although the laser 
has an 80 MHz repetition rate, in these studies we used it 
in quasi-continuous wave mode. We chose to use an NIR 
fluorophore and laser combination because attenuation 
and autofluorescence of biological tissue is well-known to 
be significantly reduced versus blue or green wavelength 
ranges.15 The output wavelength of the laser was set to 
740 nm (which matched the absorption spectra of the AF 750 
and Cy7.5 dyes). The output of the beam was filtered with a 
730 nm “clean up” filter with 30 nm bandpass (z730/30 nm; 
Chroma Technology, Rockingham, VT, USA) to remove any 
out-of-band NIR laser output. The 1 mm diameter beam was 
expanded to approximately 150 cm in diameter using a lens 
pair in simple telescope configuration (f=50 mm and 200 mm; 
Edmund Optics, Barrington, NJ, USA) followed by a third 
expanding plano-concave lens (f=-25 mm; Edmund Optics). 
The power at the sample was adjusted using a set of neutral 
density filters and was approximately 15 mW (equivalent to 
0.015 mW/cm2) for these experiments. A ground glass dif-
fuser plate was placed under the samples to create a relatively 
homogeneous illumination profile and remove any speckle 
or interference pattern from the illumination light.
Samples were imaged with a high-sensitivity electron-
multiplied charge coupled device camera (iXonEM +855; 
Andor Technology, Belfast, Northern Ireland) fitted with a 
35 mm lens (NT54-689, Edmund Optics). The imaging field 
of view was 105×105 mm at a working distance of 47 cm. 
Each image was 1,004×1,006 pixels. Camera exposure time 
and image acquisition were controlled using a personal com-
puter running Andor control software. Although the camera 
could be operated with intensifier gain, this was turned off for 
the experiments described later. The camera was fitted with 
either a 740 nm filter (to record “intrinsic” images at the laser 
wavelength), with a 40 nm bandpass (et740/40m, Chroma 
Technology) or a 780 nm longpass filter (et780lp, Chroma) 
to collect fluorescent light from the sample. The filters were 
mounted in a five-position filter wheel (LCFW5; Thorlabs, 
Newton, NJ, USA). White light images of the sample were 
acquired by moving the filter wheel to an open position so 
that all wavelengths were detected by the camera. Mice were 
top-illuminated with a white light source (Fiber Optic Illumi-
nator Model 190; Dolan-Jenner Industries, Lawrence, MA, 
USA), whereas clear agar phantoms were back-illuminated 
with a light emitting diode ring (Digi-Slave L-Ring 3200; 
Edmund Optics).
Agar phantom preparation and imaging
Agar phantoms were placed on the imaging platform and 
trans-illuminated as described earlier. The movement of free 
AF 750 dye (Molecular Probes, Thermo Fisher Scientific), 
30 nm NPs, and 200 nm NPs were tested in separate experi-
ments to observe the effect of particle size on diffusion. Free 
dye and NPs were injected directly into the clear phantom 
with an insulin syringe from the top of the phantom to cre-
ate a ~1 mm diameter vertical reservoir in the center of the 
dish. We note that the thickness of the phantom (10 mm) 
was very small relative to the total diameter of the phantom 
(240 mm). The phantoms were made in 250 mm diameter by 
25 mm deep cell culture dishes (Corning Incorporated, Corn-
ing, NY, USA). The phantom material was made with 1.5 g 
of agarose (Acros Organics, Geel, Belgium) and 250 mL of 
distilled water resulting in 0.6% agar gel. The mixture was 
boiled for 10 minutes until the powdered agar was dissolved 
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Figure 2 Our custom built fluorescence imaging system.
Notes: (A) schematic and (B) photograph of the fluorescence imager used to acquire image sequences for this work.
Abbreviations: M, mirror; LP, longpass filter; BP, bandpass filter; WL, white light; EMCCD, electron-multiplied charge coupled device; PC, personal computer.
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and then poured into the cell culture dish to cool and harden. 
We used 0.6% agarose phantoms because this model has been 
shown previously to mimic flow properties of a number of 
biological tissues including the brain.16–18 For experiments 
involving free dye, AF 750 was injected into the agar phantom 
and images were acquired at 15-minute intervals for a total 
of 3 hours (N=3). In this case, it was possible to continuously 
take measurements without removal of the phantom from 
the glass diffuser. Exposure times were 1 millisecond for 
intrinsic images (ie, at the wavelength of the laser) and were 
between 0.5 and 4 seconds for fluorescence images, depend-
ing on the acquisition time point (later times required longer 
exposures due to dye diffusion and dilution). For experiments 
involving NPs (30 and 200 nm diameter), the phantoms 
were imaged daily for 15 days after the injection of the NPs 
(N=3). To prevent drying of the agar, these phantoms were 
refrigerated between experiments. A wire marker was placed 
in the upper left hand corner to allow image co-registration 
between imaging sessions. For NP formulations, fluorescence 
images required between 0.5 and 30 seconds exposures (as 
aforementioned, longer exposures were required for later time 
points). White light images were taken of the phantoms by 
back-illumination with the light emitting diode ring during 
each imaging session.
In vivo experiments
Animal experiments were conducted in agreement with 
all relevant guidelines and regulations set by Northeastern 
University – Institutional Animal Care and Use Committee, 
and with approved institutional protocols by the American 
Association of Laboratory Animal Care. Six 6-week-old 
male athymic nude mice (Hsd:Athymic Nude-Foxn1nu) were 
procured from Charles River lab, and were housed in a group 
of six in standard cages with free access to food and water 
and a 12-hours light/dark cycle. All animals acclimated to 
the animal facility for at least 48 hours before experimenta-
tion. All possible parameters that may cause social stress, 
such as group size, type (treated and non-treated), among the 
experimental animals were carefully monitored and avoided. 
Animals were observed daily for any behavioral abnormali-
ties and weighed weekly.
INCeRT spacers were implanted subcutaneously in mice 
using a sterile clinical brachytherapy applicator needle. Two 
NP or free-dye coated spacers were implanted in the left and 
right rear flanks of nude mice (N=4 spacers per case). Three 
groups of spacers were studied: 1) PLGA spacer doped with 
Cy7.5 free dye, 2) PLGA spacer doped with conCy7.5-NPs 
with average diameter 30 nm, 3) PLGA spacer doped 
with conCy7.5-NPs with average diameter 200 nm. Each 
mouse was imaged once per day for 15 days following 
implantation. It is important to note that the mice were 
imaged in trans-illumination mode (as opposed to reflec-
tion mode). As we discussed, trans-illumination imaging 
(combined with image normalization) is significantly more 
quantitatively accurate when imaging in deep tissue with 
significant optical inhomogeneities. During imaging, mice 
were placed on a custom mask to avoid saturation of the 
camera by direct laser illumination. Three sets of images 
were acquired during each imaging session as follows: 
first, white light images were acquired with a 1 second 
exposure time. Second, intrinsic images (at the wavelength 
of the laser) were acquired with the 740 nm filter in front of 
the camera and 5 milliseconds exposure times. This “intrin-
sic” image was used for normalization of the fluorescence 
images to improve quantitative accuracy.19 Third, fluores-
cence images were acquired with the 780 nm filter in front 
of the camera and exposure times were between 7.5 and 
100 seconds, depending on the imaging time point.
Image processing and data analysis
We first performed basic pre-processing and normalization 
as follows. First, a dark field image was acquired (by capping 
the lens) and then subtracted from each image. All images 
were normalized to exposure time and laser intensity (which 
was measured on each day) so that the units were in photon 
counts/s/mW. Next, fluorescence images were normalized by 
pixel-by-pixel division by the corresponding intrinsic image. 
Other authors have shown previously that this normalization 
operation improves the accuracy of fluorescence images – 
particularly when imaged in trans-illumination geometry – since 
it accounts for the laser illumination profile and minor differ-
ences in illumination intensity. Normalization also improves 
quantitative accuracy in the presence of tissue optical property 
heterogeneities and improves imaging depth.19
Phantoms
Each of the data sets for agar phantoms injected with either 
free AF 750 dye, 30 nm, or 200 nm NPs was analyzed by first 
finding the center of the injection site using a custom written 
MATLAB (MathWorks, Natick, MA, USA) routine. Here, 
we have assumed that the physical diffusion of the free dye 
and NPs was isotropic in the agar. Images were then averaged 
radially from this center point for each time point. These 
intensity curves were then fit to a simple one dimensional 
diffusion equation with a point source:
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where I(x,t) was the intensity at each time and position, 
A
0
 was the total amount of diffusing substance, D was the 
diffusion coefficient, t was the time following injection, and 
x was the radial distance from the source.20 Equation 1 was 
fit to the averaged experimental data for each injection type 
to yield the diffusion coefficient D. The complete spatial and 
temporal profiles were used in each fit for each case.
In vivo data
The diffusion process in vivo is significantly more complex 
than in agar phantoms – for example, due to active transport 
of NPs away from the site of injection, tissue boundaries and 
inhomogeneities, and light diffusion – which prevented fitting 
of the simple diffusion equation as earlier. Therefore, diffu-
sion of NPs and AF 750 dye from the implanted spaces was 
quantified using three additional metrics: i) diffusion area, 
ii) diffusion profile, and iii) spacer intensity. For the first 
(diffusion area), we considered the maximum fluorescent inten-
sity for each time point and then computed the fluorescence 
area for pixels exceeding 50% of this value on each day (ie, the 
“full width at half maximum area”). Pixel numbers were con-
verted to area (in mm2) using the calibrated image pixel size of 
0.011 mm2. This area was calculated for each spacer and 
for each time point (N=4 for each). Second, we computed 
intensity (diffusion) profiles for the spacers at each time 
point. Since spacer orientation differed between mice, we first 
applied a thresholding routine to automatically identify the 
long and short axes of the cylindrically shaped spacer in the 
in vivo fluorescence images. Next, the fluorescence profiles 
were computed by averaging eleven lines orthogonal to the 
long axis of each spacer. Third, the mean fluorescence inten-
sity of each spacer was computed as a function of time.
Results
In vitro characterization of NPs and 
spacers
Dynamic light scattering was used to determine the hydro-
dynamic diameter of the conCy7.5-NP. Two batches were 
prepared: one with an average diameter of 30 nm and the 
other with an average diameter of 200 nm particles. These 
sizes were confirmed using transmission electron micros-
copy as shown in Figure 1B and C, respectively. Spacers 
were flash frozen then fractured and mounted for scanning 
electron microscopy imaging. The cross-sectional image in 
Figure 1D shows an overall uniform distribution of the silica 
across the face of the spacer with additional panels showing 
the magnified distribution. Chemical analysis confirmed the 
pockets in the region of interest to be silica NPs.
Phantom results
The fluorescence images measured from agar phantoms 
injected with AF 750, 30 nm NPs, and 200 nm particles are 
shown in Figure 3A–D, E–H, and I–L, respectively. As is 
evident from these image sequences, the free dye diffused 
significantly more rapidly than the NPs (ie, on the order of 
minutes versus days) due to their larger size. As described 
earlier, normalized corrected fluorescent profiles were com-
puted and are shown in Figure 4A–C for the three sets of 
injections. By inspection of these figures, diffusion of the NPs 
was small but significant over the 15-day period, whereas the 
diffusion of the free dye occurred rapidly over the span of 
a few hours. In all cases, the measured fluorescence inten-
sity steadily decreased over time. This is shown explicitly 
in Figure 4D, where the maximum intensity is shown as a 
function of measurement time (intensity data for the free dye 
is shown in Figure 4D inset). In combination, Figure 4A–D 
indicates the anticipated size-dependent diffusion behavior, 
ie, that the larger NPs diffused less than either the smaller NPs 
or the free dye. Likewise, the one-dimensional diffusion equa-
tion (Equation 1) was then fit to the data from Figure 4A–C. 
The resulting diffusion coefficients (D) for each of the three 
sets of phantoms are shown in Figure 4E. As shown, the 
diffusion coefficient for the free dye was 24.92 mm2/day, 
0.02 mm2/day for 30 nm NPs, and 0.01 mm2/day 
for 200 nm NPs. This agrees well with visual inspection of 
the diffusion behavior in Figure 4A–D and the anticipated 
size-dependency.
In vivo results
Spacers coated with either free dye (Cy7.5), 30 nm, or 200 nm 
NPs were implanted in the rear flanks of nude mice (N=4 for 
each) and then imaged daily for 15 days. Example represen-
tative image sets obtained for implanted spacers at a single 
time point in vivo are shown in Figure 5. A white light image 
of the mouse is shown in Figure 5A, with the position of the 
implanted spacers indicated by the red arrows. The normalized 
fluorescence image is shown in Figure 5B. For anatomical 
reference, an overlay of the normalized fluorescence image 
over the white light image of the animal is shown in Figure 5C. 
After the animals were euthanized, we also removed the skin 
layer and the spacers to image the residual fluorophores and 
NPs without light scatter due to the skin tissue. As shown in 
Figure 5D (in this case for Cy7.5 coated spacer), the residual 
fluorescence was still clearly visible and demonstrates the 
continuous diffusion from the spacer over time.
Time-series images for each of the three-spacer types 
(repre sentative images) are shown in Figure 6. As is indicated, 
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all of the spacers decreased in intensity over time due to 
continuous diffusion of the fluorescence from the spac-
ers, and larger decrease was observed for spacers coated 
with NPs compared to free dye. Likewise, the fluorescence 
area appeared to increase over time due to this diffusion 
process. This is shown explicitly in Figure 7. The diffu-
sion profiles for the free dye, 30 nm, and 200 nm NPs as a 
function of distance from the spacer over time are shown 
in Figure 7A–C, respectively. A small amount of diffusion 
(~1 mm) beyond the profile measured on day 1 is evident in 
all cases (we note that the diffusion profile observed on day 1 
is principally due to light diffusion in scattering biological 
tissue, as opposed to fluorophores or NP diffusion from the 
spacer). The normalized fluorescence intensity for each case 
is shown in Figure 7D, indicating continuous diffusion of the 
fluorophores and NPs over time. Likewise, the full width at 
half-maximum fluorescence area is shown in Figure 7E. As 
shown, the area of diffusion reached its maximum on day 4 for 
the 30 nm NPs and day 6 for the 200 nm particles, indicating a 
size-dependence of the process (ie, diffusion was slower with 
the larger NPs). The fluorescence area decreased after this 
maxima,  presumably due to active transport of the NPs away 
from the site of the spacer, for example, by blood vessels.
Discussion and conclusion
INCeRT represents a new strategy for local tumor control 
by which previously inert spacers are doped with drug-
delivering NPs that diffuse from the biodegradable implant 
continuously over time. Ideally, NPs will be optimized so that 
they diffuse several mm from the implant site and are retained 
in the tissue for weeks, ie, to treat a large tumor volume for an 
extended time period. Optimization of these diffusion proper-
ties is difficult to measure in vivo. Therefore, in this work, we 
developed and validated a new custom fluorescence imaging 
platform to directly visualize and quantify diffusion of NPs 
in gel phantoms in vitro and in mice in vivo. In both cases, 
we observed size-dependent diffusion profiles as expected. 
In phantoms, this was a straightforward relationship that was 
well modeled by a one dimensional diffusion equation. In 
vivo, size-dependent diffusion was also observed, but was 
significantly more complex as we have noted earlier, due 
to both light propagation effects in biological tissue and 
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Figure 3 Fluorescence image sequences for free dye, 30 nm NP, and 200 nm NP diffusion over time.
Notes: (A–D) Fluorescence image sequence of a representative phantom with Alexa Fluor 750 dye diffusion at 1, 15, 30, and 60 minutes, respectively. (E–H) Fluorescence 
image sequence showing 30 nm nanoparticle phantom diffusion for 1 minute, 6, 11, and 15 days. (I–L) Fluorescence image sequence showing 200 nm nanoparticle phantom 
diffusion for 1 minute, 6, 11, and 15 days. All images are normalized to the maximum at minute 1.
Abbreviation: NP, nanoparticle.
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Figure 4 Diffusion (fluorescence) as a function of distance from the phantom center, averaged over all phantoms imaged (N=3) and normalized to the intensity at x=0 for 
each time point.
Notes: Data for (A) free aF 750 dye, (B) 30 nm nanoparticles, and (C) 200 nm nanoparticles are shown. (D) Average maximum fluorescence intensity normalized to initial 
time point per phantom type showing the continual decrease in maximum fluorescence over time. Inset time scale of free AF 750 dye diffusion is on the order of minutes 
compared to days in part (D). (E) Diffusion coefficients found by fitting the diffusion profile curves to I x t
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Abbreviations: aF, alexa Fluor; NPs, nanoparticles.
Figure 5 Example in vivo fluorescence image sequence of Cy7.5 spacers.
Notes: (A) White light image of a mouse with red arrows indicating the location of the implanted spacers, (B) normalized fluorescence image, (C) normalized fluorescence 
image overlaid on white light image at minute 1, and (D) overlaid fluorescence image acquired on day 15 after dissection of spacer from the mouse.
Abbreviation: cy7.5, cyanine 7.5.
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active transport mechanisms that carry away NPs in tissue. 
However, in this proof-of-concept study we were able to 
confirm that NPs are indeed observed in tissue for weeks after 
implanting INCeRT spacers and are therefore not rapidly 
removed from the site.
This work provides an imaging platform by which the 
NPs can be further optimized for diffusion characteristics 
both in vitro and in vivo. The focus of future studies will 
be to characterize the influence of size, charge, pH, and 
tumor microenvironment on NP diffusion. Ongoing work 
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Figure 6 Example in vivo image sequence of Cy7.5 spacers in row 1 (top row), 30 nm NP spacers in row 2, and 200 nm NP spacers in row 3.
Notes: Each row represents the changes over the 15 days of a specific spacer. The images in each row are normalized to minute 1.
Abbreviations: cy7.5, cyanine 7.5; NPs, nanoparticles.
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Figure 7 Averaged fluorescence diffusion curves over all spacers imaged (N=8), normalized to the intensity at x=0 per time point.
Notes: (A) cy7.5 dye spacers, (B) 30 nm nanoparticle spacers, and (C) 200 nm nanoparticle spacers. (D) The average maximum spacer fluorescence intensity normalized 
to initial time point showing the continual decrease in maximum fluorescence over time. (E) The fluorescence area imaged (full width at half maximum) around the spacer as 
a function of time, averaged over all trials. As indicated, diffusion occurred continuously over time, with the maximum diffusion area observed on day 4 for 30 nm NPs, day 6 
for 200 nm NPs, and continuously increasing area observed for free dye.
Abbreviations: cy7.5, cyanine 7.5; NPs, nanoparticles.
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involves use of our platform for optical measurement of 
NP diffusion from INCeRT spacers in alternate anatomical 
locations and tumor models, for example in prostate cancer 
where brachytherapy is often used as a salvage therapy in 
patients clinically.6,21 Understanding the release intratumor-
ally will help optimize the spacer parameters to deliver the 
chemotherapeutic/radiosensitizer at sufficient doses for 
therapeutic efficacy for the entirety of the brachytherapy dose 
regimen. Our research interests lie in treating early stage, slow 
progressing, non-metastatic prostate cancer, and in salvage 
cases such as recurrence, where brachytherapy or internal 
radiation therapy is a common mode of treatment. During 
brachytherapy, clinicians space brachytherapy seeds with 
inert biocompatible spacers for highly controlled dosing of 
the prostate.21–23 Recurring tumor treatment is limited by pre-
viously given treatments due to the toxicity to the patient.24,25 
Adding an implant to brachytherapy can reduce the toxicity 
seen to healthy tissue while radiosensitizing the local prostate 
tumor for a greater chance of therapeutic effect, acting as a 
slow release drug depot for simultaneous combinatorial chemo 
and radiation therapy. The robust platform can be tailored for 
a controlled and continuous release of the drug/radiosensitizer 
from the spacer for a sustained local delivery of high therapeu-
tic dose optimal for long-term brachytherapy treatments.
As we have demonstrated, NIR imaging has distinct 
advantages in that it allows us to image the same animal 
serially over the course of weeks, non-invasively, and at a 
relatively low cost. We developed and used a custom imaging 
system because it allowed us to flexibly select the excitation 
and emission wavelengths specific to the fluorochrome of 
interest (which could be altered in the future if needed), and 
since it allows us to image mice in trans-illumination geometry 
and perform the image normalization procedure described 
herein. Moreover, the system’s spatial resolution and field 
of view allowed us to observe and quantify the NP diffusion 
both in vitro and in vivo. In the future, we could potentially 
also incorporate higher-resolution structural imaging data (for 
example, from magnetic resonance imaging, X-ray-computed 
tomography, or opto-acoustic imaging) to improve quantifica-
tion of NP diffusion in complex tissues. The imaging platform 
demonstrated in this work can be used to determine the release 
profile of these spacers to alter the parameters of the implant 
for an optimized release profile to mimic that of what is seen 
in brachytherapy for sustained combinatorial treatment.
Disclosure
This work was supported by Integrative Graduate Educa-
tion and Research Traineeship Nanomedicine Science and 
Technology NSF-DGE-0965843 (principal investigator 
S Sridhar), fellowships to J Belz and S Markovic, and a 
Massachusetts Life Sciences Center New Investigator Award 
to M Niedre. The authors report no other conflicts of interest 
in this work.
References
 1. Implants in Drug Delivery. In: Ranade VV, Cannon JB, editors. Drug 
Delivery Systems. 3rd ed. Boca Raton, Florida: CRC Press; 2011.
 2. Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and 
pharmacodynamics of a sustained-release dexamethasone intravitreal 
implant. Invest Ophthalmol Vis Sci. 2011;52(1):80–86.
 3. Cormack RA, Sridhar S, Suh WW, D’Amico AV, Makrigiorgos GM. 
Biological in situ dose painting for image-guided radiation therapy 
using drug-loaded implantable devices. Int J Radiat Oncol Biol Phys. 
2010;76(2):615–623.
 4. Friedland JL, Freeman DE, Masterson-McGary ME, Spellberg DM. 
Stereotactic body radiotherapy: an emerging treatment approach 
for localized prostate cancer. Technol Cancer Res Treat. 2009;8(5): 
387–392.
 5. Sylvester JE, Grimm PD, Eulau SM, Takamiya RK, Naidoo D. 
Permanent prostate brachytherapy preplanned technique: the modern 
Seattle method step-by-step and dosimetric outcomes. Brachytherapy. 
2009;8(2):197–206.
 6. Kumar R, Belz J, Markovic S, et al. Nanoparticle-based brachytherapy 
spacers for delivery of localized combined chemoradiation therapy. 
Int J Radiat Oncol Biol Phys. 2015;91(2):393–400.
 7. National Cancer Institute [homepage on the Internet]. Prostate Cancer 
Treatment (PDQ®). NIH National Cancer Institute; 2014. Available 
from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/
Patient. Accessed December 6, 2015.
 8. Tishler RB, Geard CR, Hall EJ, Schiff PB. Taxol sensitizes 
human astrocytoma cells to radiation. Cancer Res. 1992;52(12): 
3495–3497.
 9. Castro Kreder N, Van Bree C, Franken NA, Haveman J. Effects of 
gemcitabine on cell survival and chromosome aberrations after pulsed 
low dose-rate irradiation. J Radiat Res. 2004;45(1):111–118.
 10. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin 
Chem Biol. 2003;7(5):626–634.
 11. Lin Y, Weissleder R, Tung CH. Novel near-infrared cyanine fluoro-
chromes: synthesis, properties, and bioconjugation. Bioconjug Chem. 
2002;13(3):605–610.
 12. Ghoroghchian PP, Therien MJ, Hammer DA. In vivo fluorescence 
imaging: a personal perspective. Wiley Interdiscip Rev Nanomed 
Nanobiotechnol. 2009;1(2):156–167.
 13. Kumar R, Roy I, Ohulchanskyy TY, et al. Covalently dye-linked, 
surface-controlled, and bioconjugated organically modified silica nano-
particles as targeted probes for optical imaging. ACS Nano. 2008;2(3): 
449–456.
 14. Kumar R, Roy I, Ohulchanskky TY, et al. In vivo biodistribution and 
clearance studies using multimodal organically modified silica nano-
particles. ACS Nano. 2010;4(2):699–708.
 15. Wang L, Wu H, Biomedical Optics: Principles and Imaging. 1st ed. 
Hoboken (NJ): Wiley-Interscience; 2007.
 16. Chen ZJ, Gillies GT, Broaddus WC, et al. A realistic brain tissue phan-
tom for intraparenchymal infusion studies. J Neurosurg. 2004;101(2): 
314–322.
 17. Cubeddu R, Pifferi A, Taroni P, Torricelli A, Valentini G. A solid tissue 
phantom for photon migration studies. Phys Med Biol. 1997;42(10): 
1971–1979.
 18. Pomfret R, Miranpuri G, Sillay K. The substitute brain and the potential 
of the gel model. Ann Neurosci. 2013;20(3):118–122.
 19. Ntziachristos V, Turner G, Dunham J, et al. Planar fluorescence imaging 
using normalized data. J Biomed Opt. 2005;10(6):064007.
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
 MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2016:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1223
Near-infrared fluorescence imaging platform of nanoparticle spacers
 20. Crank J. The Mathematics of Diffusion. 2nd ed. New York: Oxford 
University Press; 1979.
 21. Martin JM, Handorf EA, Kutikov A, et al. The rise and fall of prostate 
brachytherapy: use of brachytherapy for the treatment of localized 
prostate cancer in the National Cancer Data Base. Cancer. 2014; 
120(14):2114–2121.
 22. American Cancer Society [homepage on the Internet]. Prostate 
Cancer That Remains or Recurs after Treatment. American Cancer 
Society; 2015. Available from: http://www.cancer.org/cancer/pros-
tatecancer/detailedguide/prostate-cancer-treating-recurrence. Accessed 
December 6, 2015.
 23. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An 
assessment of quality of life following radical prostatectomy, high dose 
external beam radiation therapy and brachytherapy iodine implanta-
tion as monotherapies for localized prostate cancer. J Urol. 2007; 
177(6):2151–2156.
 24. Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing 
conventional-dose with high-dose conformal radiation therapy in early-
stage adenocarcinoma of the prostate: long-term results from proton 
radiation oncology group/american college of radiology 95-09. J Clin 
Oncol. 2010;28(7):1106–1111.
 25. Kuban DA, Tucker SL, Dong L, et al. A long-term results of the 
M. D. Anderson randomized dose-escalation trial for prostate cancer. 
Int J Radiat Oncol Biol Phys. 2008;70(1):67–74.
